Last reviewed · How we verify

YYC301-1 & YYC301-2 & YYC301-3

Yooyoung Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

YYC301-1 & YYC301-2 & YYC301-3 is a Small molecule drug developed by Yooyoung Pharmaceutical Co., Ltd.. It is currently in Phase 3 development. Also known as: YYC301-1: Tramadol 37.5Mg+ Celecoxib 200mg, YYC301-2: Tramadol 75mg+ Celecoxib 200mg, YYC301-3: Tramadol 150mg+ Celecoxib 200mg.

YYC301-1, YYC301-2, and YYC301-3 are investigational drugs with unknown mechanisms of action.

At a glance

Generic nameYYC301-1 & YYC301-2 & YYC301-3
Also known asYYC301-1: Tramadol 37.5Mg+ Celecoxib 200mg, YYC301-2: Tramadol 75mg+ Celecoxib 200mg, YYC301-3: Tramadol 150mg+ Celecoxib 200mg
SponsorYooyoung Pharmaceutical Co., Ltd.
ModalitySmall molecule
PhasePhase 3

Mechanism of action

Further information on their mechanisms is not available.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about YYC301-1 & YYC301-2 & YYC301-3

What is YYC301-1 & YYC301-2 & YYC301-3?

YYC301-1 & YYC301-2 & YYC301-3 is a Small molecule drug developed by Yooyoung Pharmaceutical Co., Ltd..

How does YYC301-1 & YYC301-2 & YYC301-3 work?

YYC301-1, YYC301-2, and YYC301-3 are investigational drugs with unknown mechanisms of action.

Who makes YYC301-1 & YYC301-2 & YYC301-3?

YYC301-1 & YYC301-2 & YYC301-3 is developed by Yooyoung Pharmaceutical Co., Ltd. (see full Yooyoung Pharmaceutical Co., Ltd. pipeline at /company/yooyoung-pharmaceutical-co-ltd).

Is YYC301-1 & YYC301-2 & YYC301-3 also known as anything else?

YYC301-1 & YYC301-2 & YYC301-3 is also known as YYC301-1: Tramadol 37.5Mg+ Celecoxib 200mg, YYC301-2: Tramadol 75mg+ Celecoxib 200mg, YYC301-3: Tramadol 150mg+ Celecoxib 200mg.

What development phase is YYC301-1 & YYC301-2 & YYC301-3 in?

YYC301-1 & YYC301-2 & YYC301-3 is in Phase 3.

Related